AU7580187A - Androstane-type and cortical aminoesters - Google Patents

Androstane-type and cortical aminoesters

Info

Publication number
AU7580187A
AU7580187A AU75801/87A AU7580187A AU7580187A AU 7580187 A AU7580187 A AU 7580187A AU 75801/87 A AU75801/87 A AU 75801/87A AU 7580187 A AU7580187 A AU 7580187A AU 7580187 A AU7580187 A AU 7580187A
Authority
AU
Australia
Prior art keywords
aminoesters
androstane
cortical
type
cortical aminoesters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75801/87A
Inventor
Donald Emory Ayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AU7580187A publication Critical patent/AU7580187A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU75801/87A 1986-06-23 1987-06-09 Androstane-type and cortical aminoesters Abandoned AU7580187A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87741486A 1986-06-23 1986-06-23
US87741386A 1986-06-23 1986-06-23
US877414 1986-06-23
US877413 1986-06-23

Publications (1)

Publication Number Publication Date
AU7580187A true AU7580187A (en) 1988-01-12

Family

ID=27128438

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75801/87A Abandoned AU7580187A (en) 1986-06-23 1987-06-09 Androstane-type and cortical aminoesters

Country Status (2)

Country Link
AU (1) AU7580187A (en)
WO (1) WO1987007895A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2644788B1 (en) * 1989-03-22 1995-02-03 Roussel Uclaf NOVEL 3-CETO STEROIDS COMPRISING AN AMINO-SUBSTITUTED 17-CHAIN, THEIR PREPARATION METHOD AND THE INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2644789B1 (en) * 1989-03-22 1995-02-03 Roussel Uclaf NOVEL 19-NOR, 3-CETO STEROIDS COMPRISING AN AMINOSUBSTITUTED 17-CHAIN, THEIR PREPARATION METHOD AND THE INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2644787B1 (en) * 1989-03-22 1995-02-03 Roussel Uclaf NOVEL AMINOSUBSTITUTED STEROIDS 21, THEIR PREPARATION PROCESS AND THE INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0513177A1 (en) * 1990-01-26 1992-11-19 The Upjohn Company 5-oxygenated-2,4,6-triaminopyrimidines
US5502187A (en) * 1992-04-03 1996-03-26 The Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
HU9201904D0 (en) 1992-06-09 1992-09-28 Innomedika Szoevetkezet Laboratorial sem-automatic disclosing appartus operating with microwaves, equipped with teflone dividing and destructor holding devices, int two varieties one with controlled supercooling, another with energy dissipating unit
HU209678B (en) 1992-06-09 1994-10-28 Richter Gedeon Vegyeszet Process for producing biologically active eburnamenin-14-carbonyl-amino derivatives and pharmaceutical compositions containing them
HU214331B (en) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Methods for producing piperazine and homopiperazine derivatives and pharmaceutical compositions containing them
DE4312034A1 (en) * 1993-04-13 1994-10-20 Hesch Rolf Dieter Prof Dr Med Novel androgens and anabolic steroids
NZ298499A (en) * 1995-01-11 1998-01-26 Samjin Pharm Co Ltd Aromatic piperazine or pyridine derivatives; medicaments thereof
DK2278978T3 (en) 2008-05-28 2015-09-21 Reveragen Biopharma Inc NON-HORMONAL STEROID MODULATORS OF NF-KB FOR TREATMENT OF DISEASE
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005836A (en) * 1956-08-31 1961-10-24 Pfizer & Co C Salts of steroidal amino acid esters
BE621470A (en) * 1961-08-17
US4260736A (en) * 1978-08-14 1981-04-07 Kureha Kagaku Kogyo Kabushiki Kaisha Steroid hormone-antitumor derivatives
FR2459249A1 (en) * 1979-06-14 1981-01-09 Fabre Sa Pierre Topical antiinflammatory steroid amino:alkanoate ester(s) - esp. prednisolone-21-ester(s) with reduced tendency for systemic absorption

Also Published As

Publication number Publication date
WO1987007895A1 (en) 1987-12-30

Similar Documents

Publication Publication Date Title
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
AU8308987A (en) Implant
AU7923587A (en) Prints and production method thereof
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
EP0233059A3 (en) Oral compositions and method
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
EP0256561A3 (en) Sweet and process for its preparation
AU601996B2 (en) Shampoo method and composition
AU7580187A (en) Androstane-type and cortical aminoesters
AU587721B2 (en) Large stub bottles and mated combination unit
AU7313387A (en) Well preforating apparatus and method
AU586559B2 (en) Combination stretcher and stairchair
AU5508086A (en) Racket
AU6863387A (en) Lithium-aluminum-silicate glass and manufacture
EP0255801A3 (en) Anilinotriazines and their use
IL84418A (en) Elastomers and their preparation
AU8269787A (en) Flyslag treatment
GB2190918B (en) Polyanhydride-siloxanes and polyimide-siloxanes obtained therefrom
AU1985288A (en) Boundary setting devices and method
AU7463087A (en) Sizing composition and method
AU8115387A (en) Novel hydrolase and method
AU590422B2 (en) Substituted quinoxalinediones and quinolinediones
AU4024289A (en) Selenium-sulfur compositions and uses therefor
AU7395987A (en) Vaccine